Evidence map›Paper›PMID 37963171›Full record

ArticlePloS one2023

Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa.

Makhosazane Nomhle Ndimande-Khoza, Ariana W K Katz, Sinead Moretlwe-Delany, Danielle Travill, Elzette Rousseau, Victor Omollo, Jennifer Morton, Rachel Johnson, Linda-Gail Bekker, Elizabeth A Bukusi and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Makhosazane Nomhle Ndimande-KhozaWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0003-1312-7783
Ariana W K KatzRTI International, Women's Global Health Imperative (WGHI), Berkeley, California, United States of America.ORCID 0000-0001-5742-4953
Sinead Moretlwe-DelanyWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Danielle TravillWits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Elzette RousseauDesmond Tutu Health Foundation, University of Cape Town, Cape Town, South Africa.
Victor OmolloCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Jennifer MortonDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA, United States of America.
Rachel JohnsonDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA, United States of America.
Linda-Gail BekkerDesmond Tutu Health Foundation, University of Cape Town, Cape Town, South Africa.
Elizabeth A BukusiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Jared BaetenDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA, United States of America.
Connie CelumDepartments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA, United States of America.ORCID 0000-0002-8813-3419
Ariane van der StratenCenter for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America.
Sarah T RobertsRTI International, Women's Global Health Imperative (WGHI), Berkeley, California, United States of America.ORCID 0000-0002-3318-9781
University of Washington · USUniversity of the Witwatersrand · ZADesmond Tutu HIV Foundation · ZARTI International · USKenya Medical Research Institute · KEUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEffective use of oral HIV pre-exposure prophylaxis (PrEP) has been lower among African adolescent girls and young women (AGYW) than among older women, young men who have sex with men, and serodiscordant heterosexual couples in the region. Efforts to build PrEP support have centered around peers and male partners, but the family may also play an important role. This qualitative study aimed to describe family influence on PrEP use among AGYW in in three African cities.

methodsPOWER (Prevention Options for Women Evaluation Research) was a PrEP demonstration project among 2550 AGYW (16-25 years old) in Johannesburg and Cape Town, South Africa and Kisumu, Kenya conducted from 2017 to 2020. In-depth interviews and focus group discussions were conducted with 136 AGYW participants to explore their PrEP views and experiences, including awareness and interest in PrEP; barriers and facilitators to uptake and use; the influence of family, peers, intimate partners, and community; and the key types of support for their PrEP use. Transcripts were coded and analysed thematically.

resultsThe decision to initiate PrEP was associated with fear and anxiety linked to anticipated stigma from family members, and with family's lived HIV experience. Family disclosure, especially to mothers, was important to participants, as most lived with their families and considered it essential for them to obtain their mother's approval to use PrEP. Most family members, particularly mothers, provided instrumental, emotional, informational and appraisal support to participants using PrEP, including reminders, encouragement, and problem-solving. Participants reported that family members with insufficient information about PrEP safety and efficacy and who voiced concerns were a substantial barrier to their use. However, they often became supportive after receiving more PrEP information.

conclusionFamilies, particularly mothers, can play an important role in supporting PrEP use. PrEP programmes should leverage family support to help with PrEP persistence by providing basic information to families about PrEP safety and efficacy. AGYW using PrEP should be encouraged to selectively disclose PrEP use to build support and counseled on how to disclose and address family concerns.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesAdolescentAdultAgedFemaleHomosexuality, MaleHumansKenyaMaleMothersSouth AfricaYoung AdultAnti-HIV Agents

Identifiers

PMID37963171
PMCPMC10645326
OpenAlexW4388667869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.